OBiO Tech launches Clinical Evaluation and Translation Centre for rare diseases in China

OBiO Technology, a world leading contract development and manufacturing organisation (CDMO) for cell and gene thera...

May 30, 2024 | Thursday | News
Evotec and CHDI Extend 20-Year Collaboration to Advance Huntington’s Disease Therapeutics

Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington’s disease...

May 30, 2024 | Thursday | News
Astatine to emerge as Japan-originated therapy for prostate cancer patients

A research team at Osaka University, Japan will start an investigator-initiated clinical trial for refractory prostate c...

May 28, 2024 | Tuesday | News
Singapore designs new genetic tool to investigate brain function and psychiatric disorders

Researchers from Duke-NUS Medical School in Singapore have found that a new class of light-sensitive proteins are capabl...

May 24, 2024 | Friday | News
Singapore opens doors for new developments in cancer biomarker discovery

A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovat...

May 22, 2024 | Wednesday | News
Traverse the rapid evolution of AI in combating the pediatric myopia epidemic in Asia

The urgency to address the myopia epidemic among children has never been more pressing. Recent studies reveal an al...

May 21, 2024 | Tuesday | Opinion
Australia launches new specialist ophthalmic clinical trial facility

To mark World Clinical Trials Day on May 20, Victorian Deputy Premier and Minister for Medical Research, Ben Carro...

May 21, 2024 | Tuesday | News
Singapore's AI potential and prospects to emerge as a premier clinical trials hub

As Asia establishes itself as the global hub for clinical trials, Singapore is bolstering its position as the preferred ...

May 17, 2024 | Friday | Opinion
Achieving optimal therapeutic modalities for NCDs in the APMA region

The Asia Pacific, Middle East and Africa (APMA) region represents almost half of the world's population but healthcare a...

May 16, 2024 | Thursday | Opinion
Singapore approves J&J's Bispecific Antibody treatment for Multiple Myeloma

Johnson & Johnson’s first-in-class, bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell-redirectin...

May 15, 2024 | Wednesday | News
Singapore unveils first public-private partnership center for speciality molecular testing

Singapore's National University Hospital (NUH) and leading RNA technology company, Mirxes have officialy unveiled the NU...

May 13, 2024 | Monday | Company results
Singapore suggests repurposing of existing cancer drugs to treat aggressive brain cancer

Glioblastoma is an often fatal form of brain cancer, with only five per cent of patients surviving beyond five years. Th...

May 13, 2024 | Monday | News
New biotech research and manufacturing hub opens at University of Queensland, Australia

A range of hyper accurate cancer drugs is in production at a newly opened research and manufacturing hub at The Universi...

May 10, 2024 | Friday | News
RBobay Pharma boosts CRDMO offerings with Cytiva's FlexFactory platform

Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDM...

May 9, 2024 | Thursday | News
Navigation and evaluation of the 'Long COVID' impact on Asia's public health

The SARS CoV-2 infection can cause a wide range of recurring or persistent health concerns among the populations infecte...

May 8, 2024 | Wednesday | Opinion
Singapore scientists develop high-precision tissue analysis AI tool to support drug discovery, diagnosis

A team of scientists from A*STAR’s Genome Institute of Singapore (GIS) and Bioinformatics Institute (BII) has deve...

May 8, 2024 | Wednesday | News
GIBF invests $10 M in Israel-based startup Nectin Therapeutics to advance Antibody Drug Conjugates

Guangzhou-Israel Biotechnology Fund (GIBF) has invested $10 million in Nectin Therapeutics. Israel-b...

May 6, 2024 | Monday | News
An integrated approach to combat canine rabies in Southeast Asia

Rabies is a neglected zoonotic disease caused by RNA virus from Rhabdoviridae family, potentially fatal if not treated. ...

May 6, 2024 | Monday | Opinion